Anti-Human RAGE MAb (Clone 176902)

データシート※最新のデータシートでない場合があります

• 商品コード：MAB11451-500
• メーカー：RSD
• 包装：500μg
• 価格： ¥266,000
• 在庫：無(未発注)

マイリストに追加 マイリストに追加済

• No.： 1
• 文献情報：
  Rolfes V et al. Platelets Fuel the Inflammasome Activation of Innate Immune Cells. Cell Rep 2020 05;31(6):107615
  Rolfes V et al
  2020/01/01
  
• 備考：
  Species: Human, Applications: Inhibition
• 参照：
  

• No.： 2
• 文献情報：
  Robert J et al. Cerebrovascular amyloid Angiopathy in bioengineered vessels is reduced by high-density lipoprotein particles enriched in Apolipoprotein E. Mol Neurodegener 2020 03;15(1):23
  Robert J et al
  2020/01/01
  
• 備考：
  Species: Human, Applications: Neutralization
• 参照：
  

• No.： 3
• 文献情報：
  Wu J et al. Polydatin protects against lipopolysaccharide-induced endothelial barrier disruption via SIRT3 activation. Lab Invest 2020 04;100(4):643-656
  Wu J et al
  2020/01/01
  
• 備考：
  Species: Human, Applications: Neutralization
• 参照：
  

• No.： 4
• 文献情報：
  Zhou B et al. Claudin-18-mediated YAP activity regulates lung stem and progenitor cell homeostasis and tumorigenesis. J. Clin. Invest. 2018 Mar;128(3):970-984
  Zhou B et al
  2018/01/01
  
• 備考：
  Species: Mouse, Applications: Western Blot
• 参照：
  

• No.： 5
• 文献情報：
  Robert J et al. High-density lipoproteins suppress Aβ-induced PBMC adhesion to human endothelial cells in bioengineered vessels and in monoculture. Mol Neurodegener 2017 08;12(1):60
  Robert J et al
  2017/01/01
  
• 備考：
  Species: Human, Applications: Neutralization
• 参照：
  

• No.： 6
• 文献情報：
  Pickering RJ et al. Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesis. J. Clin. Invest. 2019 Jan;129(1):406-421
  Pickering RJ et al
  2019/01/01
  
• 備考：
  Species: Mouse, Applications: Bioassay
• 参照：
  

• No.： 7
• 文献情報：
  Liu WJ et al. Autophagy-Lysosome Pathway in Renal Tubular Epithelial Cells Is Disrupted by Advanced Glycation End Products in Diabetic Nephropathy. J. Biol. Chem. 2015 Aug;290(33):20499-510
  Liu WJ et al
  2015/01/01
  
• 備考：
  Species: Human, Applications: Neutralization
• 参照：
  

• No.： 8
• 文献情報：
  Tuinman PR et al. Soluble receptor for advanced glycation end products as an indicator of pulmonary vascular injury after cardiac surgery. BMC Pulm Med 2013;13:76
  Tuinman PR et al
  2013/01/01
  
• 備考：
  Species: Human, Applications: ELISA Development
• 参照：
  

• No.： 9
• 文献情報：
  Yamakawa N et al. Proteolytic release of the receptor for advanced glycation end products from in vitro and in situ alveolar epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 2011 Apr;300(4):L516-25
  Yamakawa N et al
  2011/01/01
  
• 備考：
  Species: Rat, Applications: ELISA Development
• 参照：
  

• No.： 10
• 文献情報：
  Tam HL et al. Effects of atorvastatin on serum soluble receptors for advanced glycation end-products in type 2 diabetes. Atherosclerosis 2010 Mar;209(1):173-7
  Tam HL et al
  2010/01/01
  
• 備考：
  Species: Human, Applications: Western Blot
• 参照：
  

• No.： 11
• 文献情報：
  Sakaguchi M et al. S100A11, an dual mediator for growth regulation of human keratinocytes. Mol. Biol. Cell 2008 Jan;19(1):78-85
  Sakaguchi M et al
  2008/01/01
  
• 備考：
  Species: Human, Applications: Western Blot
• 参照：
  

• No.： 12
• 文献情報：
  Zen K et al. Receptor for advanced glycation endproducts mediates neutrophil migration across intestinal epithelium. J. Immunol. 2007 Feb;178(4):2483-90
  Zen K et al
  2007/01/01
  
• 備考：
  Species: Human, Applications: Western Blot
• 参照：